sulfanilamide has been researched along with Rosacea in 2 studies
Rosacea: A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WITTELS, W | 1 |
| GAIDAMAK, D | 1 |
| KAMINSKY, CA | 1 |
| KORDON, M | 1 |
| ROSENTAL, A | 1 |
2 other studies available for sulfanilamide and Rosacea
| Article | Year |
|---|---|
[On the treatment of rosacea and dermatitis herpetiformis Duhring with long-acting sulfonamides. (Preliminary report)].
Topics: Anti-Bacterial Agents; Dermatitis Herpetiformis; Rosacea; Sulfanilamide; Sulfanilamides; Sulfonamide | 1960 |
[Tetracycline-sulfadiazine-sulfamerazine-sulfacetamide association. Its use in acne and rosacea].
Topics: Acne Vulgaris; Anti-Bacterial Agents; Humans; Protein Synthesis Inhibitors; Rosacea; Sulfacetamide; | 1959 |